Association between hyperlipidemia and microalbuminuria in essential hypertension

被引:38
作者
Campese, VM
Bianchi, S
Bigazzi, R
机构
[1] Univ So Calif, Div Nephrol, Los Angeles, CA USA
[2] Spedali Riuniti, Unita Operat Nefrol, Livorno, Italy
关键词
hypertension; microalbuminuria; blood pressure; cardiovascular risk; urinary albumin excretion;
D O I
10.1038/sj.ki.4495390
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Some patients with essential hypertension manifest greater than normal urinary albumin excretion (UAE). A few retrospective studies have suggested that there is an association between microalbuminuria and cardiovascular risk. The reasons for this association are not well established, and they are the object of this review. Results. We found that hypertensive patients with microalbuminuria manifest greater levels of blood pressure, particularly at night. Serum levels of cholesterol, triglycerides, and uric acid in patients with microalbuminuria were higher than levels in those with normal UAE, whereas levels of high-density lipoprotein cholesterol in patients with microalbuminuria were lower than levels in patients with normal UAE. Patients with microalbuminuria manifest a greater incidence of insulin resistance, and thicker carotid arteries. After a follow-up of seven years we observed that 12 cardiovascular events occurred among 54 (21.3%) patients with microalbuminuria, and only two such events among 87 patients with normal UAE (P < 0.0002). Stepwise logistical regression analysis showed that UAE, cholesterol level and diastolic blood pressure were independent predictors of the cardiovascular outcome. The rate of clearance of creatinine from patients with microalbuminuria decreased more than did that from those with normal urinary albumin excretion. Conclusions. These studies suggest that hypertensive individuals with microalbuminuria manifest a variety of biochemical and hormonal derangements with pathogenic potential, which result in greater incidence of cardiovascular events and a greater decline in renal function than do patients with normal UAE.
引用
收藏
页码:S10 / S13
页数:4
相关论文
共 33 条
[1]   MICROALBUMINURIA IN TREATED HYPERTENSIVE MEN AT HIGH-RISK OF CORONARY-DISEASE [J].
AGEWALL, S ;
PERSSON, B ;
SAMUELSSON, O ;
LJUNGMAN, S ;
HERLITZ, H ;
FAGERBERG, B .
JOURNAL OF HYPERTENSION, 1993, 11 (04) :461-469
[2]   Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension [J].
Agrawal, B ;
Berger, A ;
Wolf, K ;
Luft, FC .
JOURNAL OF HYPERTENSION, 1996, 14 (02) :223-228
[3]   ELEVATED SERUM-INSULIN LEVELS IN PATIENTS WITH ESSENTIAL-HYPERTENSION AND MICROALBUMINURIA [J].
BIANCHI, S ;
BIGAZZI, R ;
VALTRIANI, C ;
CHIAPPONI, I ;
SGHERRI, G ;
BALDARI, G ;
NATALI, A ;
FERRANNINI, E ;
CAMPESE, VM .
HYPERTENSION, 1994, 23 (06) :681-687
[4]   DIURNAL-VARIATIONS OF BLOOD-PRESSURE AND MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION [J].
BIANCHI, S ;
BIGAZZI, X ;
BALDARI, G ;
SGHERRI, G ;
CAMPESE, VM .
AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (01) :23-29
[5]   INSULIN-RESISTANCE IN MICROALBUMINURIC HYPERTENSION - SITES AND MECHANISMS [J].
BIANCHI, S ;
BIGAZZI, R ;
GALVAN, AQ ;
MUSCELLI, E ;
BALDARI, G ;
PECORI, N ;
CIOCIARO, D ;
FERRANNINI, E ;
NATALI, A .
HYPERTENSION, 1995, 26 (05) :789-795
[6]   PREVALENCE OF MICROALBUMINURIA IN A LARGE POPULATION OF PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION [J].
BIGAZZI, R ;
BIANCHI, S ;
CAMPESE, VM ;
BALDARI, G .
NEPHRON, 1992, 61 (01) :94-97
[7]   MICROALBUMINURIA IN SALT-SENSITIVE PATIENTS - A MARKER FOR RENAL AND CARDIOVASCULAR RISK-FACTORS [J].
BIGAZZI, R ;
BIANCHI, S ;
BALDARI, D ;
SGHERRI, G ;
BALDARI, G ;
CAMPESE, VM .
HYPERTENSION, 1994, 23 (02) :195-199
[8]   Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension [J].
Bigazzi, R ;
Bianchi, S ;
Baldari, D ;
Campese, VM .
JOURNAL OF HYPERTENSION, 1998, 16 (09) :1325-1333
[9]  
BIGAZZI R, 1995, J HUM HYPERTENS, V9, P827
[10]   GROWTH-PROMOTING EFFECTS OF DIABETES AND INSULIN ON ARTERIES - AN INVIVO STUDY OF RAT AORTA [J].
CAPRON, L ;
JARNET, J ;
KAZANDJIAN, S ;
HOUSSET, E .
DIABETES, 1986, 35 (09) :973-978